Speakers - 2026

Title: Precision Medicine in Rheumatology: Biomarkers, Biologics, and Beyond

Abstract

Rheumatologic disorders are complex, heterogeneous, and immune-mediated conditions characterized by chronic inflammation, progressive joint destruction, and systemic complications. Traditional treatment approaches have largely relied on generalized immunosuppression, often resulting in variable therapeutic responses and adverse effects. The emergence of precision medicine has transformed the landscape of rheumatology by integrating molecular diagnostics, predictive biomarkers, and targeted biologic therapies to optimize individualized patient care.

This presentation explores the evolving paradigm of precision medicine in rheumatology, focusing on biomarker-guided diagnosis, therapeutic stratification, and outcome prediction. Advances in genomics, proteomics, and cytokine profiling have enabled improved risk assessment and early detection in diseases such as Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Ankylosing Spondylitis. Biomarkers including autoantibodies, inflammatory mediators, and genetic polymorphisms now support precision-based therapeutic decisions.

The development of biologic agents—such as TNF inhibitors, IL-6 receptor blockers, and JAK inhibitors—has revolutionized disease control by targeting specific inflammatory pathways. However, interpatient variability in response highlights the need for predictive modeling and personalized drug selection strategies. The talk will discuss current and emerging biologics, biosimilars, and small molecule therapies, alongside innovative drug delivery systems aimed at improving safety and long-term adherence.

Beyond pharmacotherapy, integration of artificial intelligence, digital health monitoring, and real-world data analytics is shaping the next generation of rheumatologic care. These tools enhance early diagnosis, monitor disease activity, and enable adaptive treatment modifications.

By bridging biomarkers, biologic therapeutics, and advanced analytics, precision medicine offers a transformative approach to managing chronic inflammatory joint diseases. This strategy not only improves clinical outcomes but also reduces healthcare burden and enhances quality of life for patients with rheumatic disorders.

What will the audience take away from presentation?

• Understanding of key biomarkers used in rheumatologic disease stratification.
• Insights into biologic and targeted synthetic therapies and their mechanisms.
• Knowledge of precision-based treatment selection strategies.
• Awareness of emerging technologies including AI and digital disease monitoring.
• Practical perspectives on translating precision medicine into clinical practice.